Trial intelligence / Profile preview

Quantitative EEG Neurofeedback as an Add-on Therapy For ADHD

NCT05635318Unknown

Sponsor
Assiut University
Start
Jan 2023
Primary completion
Jun 2023
01

Overview

Randomised trial in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Assiut University. Primary endpoint: Improvement of ADHD manifestations at 6 months. Status: unknown.

02

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT05635318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05635318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call